Thus, SENP2 overexpression sensitizes MM cells to bortezomib, while depletion of SENP2 results in opposite effect, correlating with increased sumoylation of IκBa and thereby in activation of NF-κB [72]. This evidence concerns the gene SENP2 and Miyoshi myopathy.